Linda Hwang is a translational research informatics project manager and a senior research associate in the MIRIAD group. Prior to joining Cedars-Sinai, she served as a cheminformatics database manager and senior research associate at TargeGen, Inc. (acquired by Sanofi-Aventis), where she led the design and development of various drug discovery informatics. Prior to work at TargeGen, Inc, Hwang was a scientist at Deltagen Research Laboratories, formerly known as Combi-Chem, Inc., that was acquired by Bristol-Myers Squibb and DuPont Pharmaceuticals in San Diego. There, she was responsible for parallel synthesis of small molecule libraries. Hwang received her bachelor of science in pharmacological chemistry from the University of California, San Diego.